Cardiac Power Output in Cardiogenic Shock Patients

Recruiting now · Early Phase 1

Conditions studied: Heart Failure, Cardiogenic Shock

In brief

The main purpose of this study is to determine whether differences in myocardial reserve predict clinical outcomes for heart failure patients.

Key facts

Study ID

NCT05700617

Run by

University of Chicago

People needed

5

Starts

2023-07-06

Expected to finish

2027-12-01

Last updated by the study team

2026-08-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• LVEF ≤ 40%
• Referred for RHC for:
• Evaluation for advanced heart failure therapies, including LVAD, OHT, temporary or long-term inotrope therapy, or counter-pulsation (temporary or long-term with NuPulse device OR
• Accurate assessment of invasive hemodynamics due to worsening clinical status, OR
• Assessment of myocardial recovery for consideration of LVAD or counter-pulsation (temporary IABP or long-term with NuPulse device) decommissioning or removal OR
• Assessment of cardiac function and valvular abnormalities prior to planned valvular surgery for MR or AI
• Estimated glomerular filtration rate (eGFR) ≥ 30 ml/min/1.73 m2
• Age ≥ 18 years-old
• Intent for admission based on RHC data

You may not qualify if…

• eGFR < 30 ml/min/1.73 m2
• Severe, non-revascularized coronary artery disease
• Concurrent acute coronary syndrome
• Age < 18 years-old
• History of significant ventricular arrhythmia without an ICD

Where it is running

• The University of Chicago — Chicago, Illinois, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.